Invivo Therapeutics

Description

• About InVivo TherapeuticsInVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Childrens Hospital and who now is affiliated with Massachusetts General Hospital. In 2011, the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. In 2015, the companys investigational Neuro-Spinal Scaffold received the 2015 Beckers Healthcare Spine Device Award. The publicly-traded company is headquartered in Cambridge, MA. For more details, visit www.invivotherapeutics.com. About the Neuro-Spinal ScaffoldFollowing acute spinal cord injury, surgical implantation of the biodegradable Neuro-Spinal Scaffold within the decompressed and debrided injury epicenter is intended to support appositional healing, thereby reducing post-traumatic cavity formation, sparing white matter, and allowing neural regeneration across the healed wound epicenter. The Neuro-Spinal Scaffold, an investigational device, has received a Humanitarian Use Device (HUD) designation and currently is being evaluated in the INSPIRE pivotal probable benefit study for the treatment of patients with complete (AIS A) traumatic acute spinal cord injury.
• 

  Headquarters:1 Kendall Square , Cambridge, Massachusetts, United States

  More
• 

  Phone Number: +1 617-863-5500

• 

  Website: https://www.invivotherapeutics.com

• 

  Employees:15

• 

  Revenue:$1 - 10M

• 

  Legal Name:Invivo Therapeutics

• Invivo Therapeutics's Social Media

  
• Is this data correct?

• |  NAICS Code: 523910  |

  Show More